Faites-nous part de vos impressions sur le Serveur terminologique, et aidez-nous à améliorer nos services! Vous avez jusqu’au 3 décembre 2024 pour répondre au sondage. Votre avis nous intéresse! En savoir plus >

Partager :

file D-dimers and different clinical applications

  • Messages : 149
il y a 2 ans 4 mois #7916 par Anil Patel
The next IFCC webinar: "D-dimers and different clinical applications" July 6, 2022

Dimers is a determination that has several applications. Its classic use is to rule out thrombosis and can be also used to predict its recurrence.

D-Dimer (DD) is a molecule that comes from the degradation of stabilized fibrin. Its presence indicates fibrinolysis secondary to the formation of a fibrin clot.

Therefore, it constitutes a specific marker of fibrinolytic activity in processes that produce excessive fibrin formation, even without being thrombotic.

In relation to cancer, it can be used to exclude thrombosis, also as a predictor of venous thromboembolism, as a prognosis of recurrence of thrombosis, and as a prognostic factor for the disease.

This webinar comprises three following presentations of 20 min each followed by 20 min of a panel discussion at the end.

Talk 1: DDIMERS AND THROMBOSIS - Dr. Gloria Ramos

Talk 2: DDIMERS AND CANCER IN PEDIATRICS - Prof. Yudiana Montenegro

Talk 3: DDIMERS AND COVID 19 - Dr. Alejandro Morales de la Vega

Schedule: 20 min per speaker plus 20 min panel discussion
Time Zones: Live presentations starting at: 11:00AM EDT-New York ; 5:00PM CET-Rome; 11:00PM CST-Beijing;
Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone. Click here to convert to your time zone.

Recorded webinar: available on demand
Certificate of participation: available for all registrants
Register here

Connexion ou Créer un compte pour participer à la conversation.

Modérateurs: Linda MonicoNaomi BrooksHelen Wu

Logo d'InfoCentral

La santé numérique à votre service

 

Transformer les soins de santé au Canada grâce aux technologies de l'information sur la santé.